Trials / Completed
CompletedNCT01703884
ANC & Malaria Diagnostic in Pregnancy
Improved Quality of ANC and Diagnostic Services for Malaria in Pregnancy
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 5,254 (actual)
- Sponsor
- Centre Muraz · Academic / Other
- Sex
- Female
- Age
- 16 Years – 50 Years
- Healthy volunteers
- Not accepted
Summary
The program's overall objective is to assess the impact of a package of interventions aimed at reducing malaria-related mortality and morbidity in pregnant women and newborns by ensuring access to a package of interventions designed to optimise the detection and treatment of malaria during pregnancy as well as improving the early detection and treatment of malaria during the third trimester.
Detailed description
This is a cluster-randomised study in which the health facility is the unit of randomisation. 16 health facilities will be randomised to intervention and control. At the community level women will be encouraged to access ANC early in the pregnancy, attend follow-up antenatal visits throughout the pregnancy and deliver at the facility. The current recommended standard of care will be provided to all women attending antenatal and obstetric care. In the intervention area, obstetric, medical, drug-exposure histories will be collected at ANC visits. In addition, in the last trimester of the pregnancy (\> 28 weeks of pregnancy), women will be systematically evaluated with selected diagnostic test for whether they have malaria parasites and treated effectively. Skilled birth attendants at the facility will be trained in emergency obstetric and neonatal care and the assessment of neonates for danger signs, low birth weight and external/observable birth defects. In the control area, women will be provided with standard practice of care. In both areas, women will be diagnosed and treated at delivery if they are positive.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | ASAQ | In the intervention area, obstetric, medical, drug-exposure histories will be collected at ANC visits. In addition, in the last trimester of the pregnancy (\> 28 weeks of pregnancy), women will be systematically evaluated with malaria RDT for whether they have malaria parasites and treated effectively with ASAQ. |
Timeline
- Start date
- 2012-08-01
- Primary completion
- 2014-07-01
- Completion
- 2014-12-01
- First posted
- 2012-10-11
- Last updated
- 2015-07-31
Locations
1 site across 1 country: Burkina Faso
Source: ClinicalTrials.gov record NCT01703884. Inclusion in this directory is not an endorsement.